Historically, prevention strategies for patients with diabetes have focused on microvascular complications and atherosclerotic cardiovascular disease; however, diabetes is now recognized to confer broad health effects, including a more than 2-fold excess risk of incident heart failure (HF)1 via biological pathways beyond atherothrombosis alone. Risk stratification tools2 and preventive strategies differ for HF and atherosclerotic cardiovascular disease in patients with diabetes—for example, sodium-glucose cotransporter 2 inhibitors can powerfully mitigate HF risk3—yet national US data characterizing the burden of and temporal trends in HF compared with ischemic heart disease (IHD) among patients with diabetes are limited.
Honigberg MC, Patel RB, Pandey A, et al. Trends in Hospitalizations for Heart Failure and Ischemic Heart Disease Among US Adults With Diabetes. JAMA Cardiol. 2021;6(3):354–357. doi:10.1001/jamacardio.2020.5921
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: